Advertisement
Screener

Bausch Health Companies Inc. (BHC) Material Contracts, 2021

Bausch Health Companies Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2021-11-02: Form 10-Q; Exhibit 10.2; Description Amendment to Employment Agreement dated April 28, 2021 between Bausch Health Companies Inc. and Paul Herendeen.†.
  • 2021-11-02: Form 10-Q; Exhibit 10.1; Description Form of 2021 Share Unit Grant Agreement (TSR Performance Restricted Share Units) under the Amended and Restated 2014 Omnibus Incentive Plan.†.
  • 2021-08-03: Form 10-Q; Exhibit 10.1; Description Employment Agreement, dated as of June 1, 2021, by and between Bausch Health Companies Inc. and Sam Eldessouky.†.
  • 2021-05-04: Form 10-Q; Exhibit 10.2; Description Form of 2021 Share Unit Grant Agreement (Performance Vesting) (Performance Restricted Share Units) under the Amended and Restated 2014 Omnibus Incentive Plan.†.
FiledFormExhibitDescription
2021-11-0210-Q10.2Amendment to Employment Agreement dated April 28, 2021 between Bausch Health Companies Inc. and Paul Herendeen.†
2021-11-0210-Q10.1Form of 2021 Share Unit Grant Agreement (TSR Performance Restricted Share Units) under the Amended and Restated 2014 Omnibus Incentive Plan.†
2021-08-0310-Q10.1Employment Agreement, dated as of June 1, 2021, by and between Bausch Health Companies Inc. and Sam Eldessouky.†
2021-05-0410-Q10.2Form of 2021 Share Unit Grant Agreement (Performance Vesting) (Performance Restricted Share Units) under the Amended and Restated 2014 Omnibus Incentive Plan.†
2021-02-2410-K10.14Form of Spinoff Bonus Program Letter Agreement dated November 2, 2020.†
2021-02-2410-K10.1Bausch Health Companies Inc. Further Amended and Restated 2014 Omnibus Incentive Plan, effective as of April 28, 2020 (the "Amended and Restated 2014 Omnibus Incentive Plan").†
2021-02-248-K10.1Director Nomination and Appointment Agreement by and among Bausch Health Companies Inc., Carl C. Icahn and the persons and entities listed therein, dated February 23, 2021.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42